Advertisement

Topics

Bayer imitates phase III study programme with Vilaprisan for symptomatic uterine fibroids treatment

09:18 EDT 4 Jul 2017 | PharmaBiz

Bayer has announced the first patient was enrolled in a phase III clinical study programme ASTEROID which will investigate vilaprisan in women suffering from uterine fibroids. Vilaprisan, discovered at Bayer, is a novel

Original Article: Bayer imitates phase III study programme with Vilaprisan for symptomatic uterine fibroids treatment

NEXT ARTICLE

More From BioPortfolio on "Bayer imitates phase III study programme with Vilaprisan for symptomatic uterine fibroids treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...